Improved planning for better results

Pharmaceutical development enters a crucial phase when the first patients get involved. The physical integrity of patients requires the greatest effort in order to avoid failure. Clinical development is costly and vulnerable to time delays. Therefore, the planning phase is paramount as a basis for reporting realistic timelines and budgets to the responsible bodies. SSS helps during this critical planning phase with a deep understanding of all the aspects – commercial, legal or clinical – relevant for companies during this absolutely critical early project stage.

Consulting for clinical research – we know what it takes

Clinical evaluation means navigating high regulatory hurdles and calls for experience and training in good clinical practice (GCP). And that’s not all. Many other factors have to be taken into account when deciding on the right strategy and to maintain clinical trial timelines and budgets. We assist our clients – whether small biotechnology companies or `Big Pharma’ – in finding the right setting. In 25 years of experience with over 250 trials, we’ve learned lots of lessons.

We advise in:

  • Regulatory consulting (country strategy, harmonized procedure, ethics)
  • Feasibility evaluation (challenges at sites and in countries, logistical and operational challenges)
  • Medical and statistical study design (patient and site numbers, interim analysis, stratification, combined clinical phases, follow-up studies, health assessment studies, blinding procedures, and much more)
© 2022 SSS International Clinical Research